Status:

COMPLETED

Gait and Balance of Diabetes Type 2 Patients

Lead Sponsor:

University Hospital, Geneva

Collaborating Sponsors:

Maastricht University Medical Center

Swiss Federal Institute of Technology

Conditions:

Diabetes Type 2

Eligibility:

All Genders

Phase:

PHASE2

PHASE3

Brief Summary

Type 2 diabetes is one of the fastest growing public health problems in both developed and developing countries. It is estimated that the number of people with diabetes in the world will double in com...

Eligibility Criteria

Inclusion

  • Past or present patient from the University Hospital in Geneva
  • Diagnosed with diabetes by the medical doctor (glycaemia \> 7 mmol on two different tests on an empty stomach)
  • Presence of a peripheral neuropathy (vibration perception ≤ 4)

Exclusion

  • Patients with a foot ulcer at the moment of intake
  • Patients with orthopaedic or chirurgical problems influencing gait parameters
  • Patients with a non diabetic neuropathy (Charcot, alcohol, Thyroid dysfunction)
  • Patients with neurological problems influencing gait parameters
  • Patients with incapacity to walk without a walking aid

Key Trial Info

Start Date :

September 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2009

Estimated Enrollment :

71 Patients enrolled

Trial Details

Trial ID

NCT00637546

Start Date

September 1 2007

End Date

March 1 2009

Last Update

January 14 2010

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospital of Geneva

Geneva, Switzerland, 1205